A systematic review of economic evaluations of treatment regimens in multiple myeloma.
Mir Mahmood AsrarDeepesh P LadShankar PrinjaDipika BansalPublished in: Expert review of pharmacoeconomics & outcomes research (2020)
The addition of novel drugs to the treatment armamentarium of MM is considerably cost-effective. The evaluations became more frequent, methodological quality has improved in the last decade.